Implementation and Testing of Enzyme Linked Immunosorbent Assay for the Detection of SARS-CoV-2 Receptor Binding Domain Antibodies

Authors

• Emilly G. Sanchez, The University of Texas MD Anderson Cancer CenterFollow
• Claudia Paindelli, The University of Texas MD Anderson Cancer Center
• Eleonora Dondossola, The University of Texas MD Anderson Cancer Center
• Sarah B. Johnson, The University of Texas MD Anderson Cancer Center
• Pranoti V. Sahasrabhojane, The University of Texas MD Anderson Cancer Center
• Khalel Imanbayev, The University of Texas MD Anderson Cancer Center
• Manoj Chelvanambi, The University of Texas MD Anderson Cancer Center
• Michael G. White, The University of Texas MD Anderson Cancer Center
• Nadim J. Ajami, The University of Texas MD Anderson Cancer Center
• Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

ELISA; RBD; SARS-CoV-2; Antibody

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

Partnership for Careers in Cancer Science and Medicine

Recommended Citation

Sanchez, Emilly G.; Paindelli, Claudia; Dondossola, Eleonora; Johnson, Sarah B.; Sahasrabhojane, Pranoti V.; Imanbayev, Khalel; Chelvanambi, Manoj; White, Michael G.; Ajami, Nadim J.; and Wargo, Jennifer A., "Implementation and Testing of Enzyme Linked Immunosorbent Assay for the Detection of SARS-CoV-2 Receptor Binding Domain Antibodies" (2021). Summer Experience 2021. 124.
https://openworks.mdanderson.org/sumexp21/124